This website uses cookies to enhance the user experience.
C

CAEDO ONCOLOGY AS926 135 082

Purchase and sale
Limited company
c/o Sharelab Gaustadalléen 21 0349 OSLO, Norge

CAEDO ONCOLOGY AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

Chairman of the board
Years since formation
4 years
since Dec 8, 2020
Type
Limited company
VAT registered
Yes
Number of employees
5

Ownership

Number of shares and share classes
104,363
1 share class
Total number of shareholders
10
8 companies, 2 persons

Financials

Annual total result 2023
-11,176,827
NOK
Total equity 2023
14,416,685
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
6.94 %
indirectly

Board

NameRoleShares
Chairman-
Board Member
9.4 %
indirectly
Board Member-

Others

NameRoleShares
U
UNIC REVISJON AS
Auditor-
S
STATEMENT AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Board Member
9.4 %
indirectly
-
9.03 %
indirectly
Managing Director/CEO
6.94 %
indirectly
-
6.94 %
indirectly
-
6.59 %
indirectly
-
4.76 %
indirectly
-
3.99 %
indirectly
-
2.65 %
indirectly
-
2.64 %
indirectly
-
1.84 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
S
SARSIA SEED FOND II AS
Ordinary shares
46,326
44.39 %
R
R OG L AS
Ordinary shares
19,242
18.44 %
K
K OG K AS
Ordinary shares
14,495
13.89 %
S
SATURN INVEST AS
Ordinary shares
13,813
13.24 %
S
STENSHAGEN INVEST AS
Ordinary shares
2,763
2.65 %
J
JAC MOE AS
Ordinary shares
2,763
2.65 %
Ordinary shares
1,920
1.84 %
F
FARVATN VENTURE AS
Ordinary shares
1,382
1.32 %
E
ERM INVEST AS
Ordinary shares
1,382
1.32 %
Ordinary shares
277
0.27 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-11,176,827
-8,523,143
-3,162,766
Total assets
16,252,953
11,509,051
1,561,484
Total liabilities
1,836,269
1,230,686
538,816
Total equity
14,416,685
10,278,366
1,022,668

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
11,186,866
8,411,907
3,156,113
Operating result
-11,186,866
-8,411,906
-3,156,113
Financial income/costs
10,038
-111,236
-6,654
Profit before tax
-11,176,827
-8,523,143
-3,162,766
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-11,176,827
-8,523,143
-3,162,766

Balance overview

Year202320222021
Total fixed assets
324,225
499,396
0
Total current assets
15,928,728
11,009,655
1,561,484
Total assets
16,252,953
11,509,051
1,561,484
Short term debt
1,836,269
953,186
538,816
Long term debt
0
277,500
0
Total liabilities
1,836,269
1,230,686
538,816
Contributed capital
33,167,352
17,852,206
1,022,668
Retained earnings
-18,750,667
-7,573,840
0
Total equity
14,416,685
10,278,366
1,022,668
Total equity and liabilities
16,252,954
11,509,052
1,561,484

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods